Clinical Trial Update: A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase III trial evaluating carboplatin as adjuvant chemotherapy for triple-negative breast cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Severance Hospital | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN